Posts

Trapped in the examples: Escaping intermediate generalisations in pharma patents

The Great Outlook Apocalypse of 2026 - Did you survive?

Post-published clinical data does not always save you (T 0251/25, Empagliflozin)

Reformatio in peius survives a procedural violation (T 1168/24)

Lack of clarity by the backdoor: An ambiguity "may simply result in a broader interpretation" (T 0977/25)

G1/25: What are the consequences?